Middle-aged people contemplating joint replacement for their arthritis should be warned

April 24,2018

Macquarie Stem Cells has provided this information to educate the public based on peer reviewed, published scientific and medical documents. We don’t aim to encourage consumers to seek out such treatments prior to an assessment by a health professional to determine your suitability for treatment. This is obtained directly from Australian Doctor. We aim to provide you with an unbiased range of treatments that are available aside from biological therapy, this is discussed in ‘supporting information>other-options’  page on our website.

Published Online: Australian Doctor – 2017

TITLE: Middle-aged people contemplating joint replacement for their arthritis should be warned of a high risk (Australian Doctor, 2017)

“As much as one in three — of needing revision surgery within the decade, say UK researchers. “(Australian Doctor, 2017)

Their large, retrospective study of nearly 120,000 people undergoing hip or knee arthroplasty found relatively low rates of implant revision in patients aged over 70 — around 5% with up to 20 years of follow-up. But for younger patients, it was a different story, with revision rates rising steadily as age decreased. Sixty-year-old patients had a 15% lifetime risk of implant revision, while for those in their early 50s, the risk rose to 29% after hip arthroplasty and 35% after knee arthroplasty.” (Australian Doctor, 2017)

“There were large differences between genders, with men in their 50s having a 15% greater risk of revision than women in the same age category. Time to revision peaked at around five years after the initial surgery, with more than half of revisions happening within six years. The authors said that until now, revision rate data had been only from older patients and their study was the first to more accurately predict risk in younger people”. (Australian Doctor, 2017)

“Young patients are likely to spend many more years than previously expected with a revision implant, which carries with it poor outcomes”, the researchers from the University of Oxford wrote in the Lancet.

In a linked commentary, two Dutch orthopaedic surgeons noted a worldwide trend towards hip and knee arthroplasties in ever younger patients, with the strongest increase in patients aged 45-55. In younger age groups, surgery tended to be more complicated, because many patients had congenital, developmental or traumatic abnormalities causing early osteoarthritis, they wrote. The current trend to implant new hips and knees in younger patients was driven by the fact that outcomes in the first few years tended to be acceptable. But increasing complications in many of these patients could mean that revision surgery was no longer viable, leading to permanent disability. “Both patients and surgeons need to be aware of this possibility, and postponing this kind of surgery, despite the realistic limitations of patients with osteoarthritis, should be considered more frequently,” they wrote.” (Australian Doctor, 2017)



REF:  Australian Doctor (2017). Middle-aged people contemplating joint replacement for their arthritis should be warned. [online] Available at: http://www.australiandoctor.com.au/news/latest-news/beware-joint-replacement-in-younger-patients [Accessed 18 Feb 2017].

Tags: Macquarie Stem Cells, Dr. Bright, Osteoarthritis Treatment, Dr. Ralph Bright, Australian Doctor


Remember, any surgical or invasive procedure carries risks. Before proceeding, you should seek a second opinion from an appropriately qualified health practitioner.

Speak with one of our consultants today